CREATED BY ELEASYS LLC

Category: endocrine system

How can a new pharmaceutical treat severe sleep disturbance a new way?

TeachableMedicalNews article 01312022

Teachable moment in classrooms:

  1. cellular basis of life chapter – concept of one gene, one protein
  2. cellular basis of life chapter – concept of gene mutation leading to protein malfunction
  3. nervous system chapter – functional roles of hypothalamus
  4. nervous system chapter – sleep and wakefulness
  5. endocrine system – receptor agonists enhance cellular response

The news item:  Recently a news item appeared about a new pharmaceutical to treat severe sleep disturbance disorders:

 

https://sleepreviewmag.com/sleep-treatments/pharmaceuticals/prescription-drugs/fda-approves-hetlioz-sleep-disturbances-smith-magenis-syndrome/

The article states that the pharmaceutical Hetlioz was approved to treat sleep disturbance disorders in adults and children, and also people suffering from Smith-Magenis syndrome.

So, Why Do I Care??  While loosing sleep hours is a common occurrence that comes with minor inconveniences in our daily lives, severe sleep disturbance, however, describes a disorder with significant health consequences. Millions of people suffer from such severe sleep disturbance in the US, and then there are over 15,000 people in the US who suffers from Smith-Magenis syndrome.

Plain English, Please!!! First let’s talk about sleep disturbances, in general. The action of going into sleep is the result of nerve signals from the hypothalamus part of the brain, and that signal decreases

How can the injection of a non-insulin medication help type 2 diabetes patients?

TeachableMedicalNews article 01172021

Teachable moment in classrooms:

  1. endocrine system chapter – insulin production by beta cells
  2. endocrine system chapter – action of hormones through receptors
  3. endocrine system chapter – action of hormones inside target cells
  4. metabolism chapter – effect of insulin on glucose utilization by body cells

The news item:  Recently a new report appeared about the diabetes treatment drug Trulicity:

FDA approves Eli Lilly’s Trulicity to reduce cardiovascular risks in type 2 diabetic patients

Eli Lilly and Co said on Friday the U.S. Food and Drug Administration has approved Trulicity for reducing cardiovascular risk factors in type 2 diabetic patients. The approval makes Trulicity the first and only type 2 diabetes drug approved to reduce heart related risks in adults with and without established cardiovascular disease, the company said in a statement.

The article states that the type 2 diabetes treatment drug was approved for reducing heart disease risk as well.

So, Why Do I Care??  About 30 million people in the US has type 2 diabetes. The disorder causes about 80,000 deaths yearly. In addition, there is a yearly $327 billion cost from lost productivity and medical cost that includes treatment for diabetic vision loss and diabetic nephropathy. Diabetes also causes heart damage. New treatments have a chance to reduce deaths and lost working hours.

Plain English, Please!!!

First, let’s talk about type 2 diabetes. Diabetes, in general, is a disorder where blood sugar (glucose) level is higher than normal for long periods of time. The continuous high blood glucose level damages small

Can peeing out blood sugar possibly save us from kidney disease?

TeachableMedicalNews article 10132019

Teachable moment in classrooms:

  1. urinary system chapter – glucose reabsorption from filtrate
  2. urinary system chapter – filtration by small blood vessels in glomerulus
  3. endocrine system chapter – insulin and insulin receptor in type 2 diabetes

 

Can peeing out blood sugar possibly save us from kidney failure?

The news item:  Recent news reports wrote about the unexpected health benefit of the type 2 diabetes drug, Invokana.

https://www.seattletimes.com/business/study-finds-diabetes-drug-may-prevent-slow-kidney-disease/

The article mentions that deaths from kidney failure, the need for dialysis, the need of kidney transplant were reduced by 30% in treated patients.

Page 2 of 2

Powered by WordPress & Theme by Anders Norén